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Previewsthese data indicate that endocardium
may not contribute significantly to cardiac
CFU-Fs, the possibility remains that
CFU-Fs of endocardial origin may be
functionally different from epicardial
CFU-Fs and require a different cell culture
medium for optimal detection.
Understanding the developmental bi-
ology of the heart is instrumental in
developing novel technologies for heart
regeneration and cellular therapies. It is
critical to identify the type and origin of
cells capable of reconstituting a heart.
To determine whether a cardiac mesen-
chymal cell compartment could be recon-
stituted by bone marrow cells after injury,
Chong et al. (2011) performed CFU-F
evaluation in the heart after transplanta-
tion of bone marrow cells following
myocardial infarction, irradiation, and
hematopoietic stem cell immobilization.
While the authors found that bonemarrow
cells could reconstitute themarrowCFU-F
compartment, they failed to detect their
contribution to cardiac CFU-Fs. These
findings support the view that bone
marrow cells do not reconstitute cardiac
cells after cardiac injury. In this context,
the activation of cardiac resident progen-
itors could be considered as a reasonable
approach to promote cardiac tissue
regeneration and vessel growth. Recentwork by Smart et al. (2011) found that
expression of embryonic epicardial
progenitor marker Wt1 can be activated
in the adult epicardium by stimulation
with thymosin b4 prior to myocardial
infarction. Subsequently, these cells
migrate into the heart and contribute to
smooth and cardiac muscles and intersti-
tial fibroblasts. Further work will be
required to determine the relationship
between epicardial progenitors described
by Smart and colleagues (Smart et al.,
2011) and cCFU-Fs identified by Chong
and colleagues (Chong et al., 2011). Do
they represent similar or hierarchically
related progenitors? Are there any stimuli
that can activate cCFU-Fs and facilitate
cardiac repair and vascularization after
myocardial infarction? Since repair
consists of a combination of regeneration
and scar formation, it is important to
determine the contribution of cCFU-Fs
to postinfarct scar formation and whether
improvement in restoration of cardiac
function can be achieved by modulation
of sclerogenic versus tissue-forming
response of cCFU-Fs. Certainly, the find-
ings presented by Chong et al. (2011)
introduce several interesting and novel
avenues of investigation, particularly in
the context of cardiac regenerative
therapies.Cell Stem Cell 9,REFERENCES
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Regulation of hematopoietic stem cell (HSC) dormancy by specific cell types in the hematopoietic niche
remains poorly understood. Yamazaki et al. (2011) now report that nerve-associated nonmyelinating
Schwann cells activate TGF-b to maintain dormant HSCs, suggesting that glia are novel players in the
bone marrow niche.Hematopoietic stem cells (HSCs) reside in
specialized microenvironments, or niches,
that ensure their localization, survival, con-
trolled proliferation, and differentiation.Components of the bone marrow (BM)
hematopoietic niche includemesenchymal
stem cells (MSCs), which secrete HSC
homing and maintenance factors; osteo-blasts, which derive from MSCs and line
the surface of the endosteum on the inside
of the bone cavity; and sympathetic nerve
fibers, which coordinate hematopoieticDecember 2, 2011 ª2011 Elsevier Inc. 493
Figure 1. Model of Glia- and Nerve-Dependent Signals in the Bone Marrow Niche
Nonmyelinating Schwann cell (Schwann cell, green) ensheathing a sympathetic axon (nerve, orange),
located in proximity of bone marrow vasculature (blood vessel, purple). Inactive TGF-b is part of the Large
Latent Complex (LLC), in which LAP sequesters TGF-b, and LTBP-1 tethers LAP (and the associated
TGF-b) to extracellular matrix (ECM). Schwann cells are thought to release active TGF-b via interactions
with Integrin avb8 and a putative matrix metalloproteinase (MMP?). TGF-b binds to its cognate receptor
on HSCs (composed of TbRII and an unknown type I receptor [TbR?]), triggering signaling pathways
that ultimately result in HSC quiescence. ‘‘Signal from Nerve’’ summarizes previously described roles of
neuron-produced neurotransmitters such as norepinephrine (NE) on MSCs, resulting in reduction of
CXCL12 levels, which in turn affects HSCs, and on HSCs directly. Although currently unknown, signals
from the sympathetic nerve may regulate Schwann cell activity (‘‘Signal from Nerve to Schwann Cell??’’).
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Previewsresponses with systemic cues and central
nervous system inputs (Ehninger and
Trumpp, 2011; Katayama et al., 2006;
Me´ndez-Ferrer et al., 2008, 2010). Consis-
tent with differences in the proliferation of
HSC populations, current models propose
an ‘‘endosteal niche,’’ which controls HSC
quiescence or dormancy, and a ‘‘vascular
niche’’ in the center of the bone cavity,
which promotes HSC self-renewal (Eh-
ninger and Trumpp, 2011). The precise
cellular interactions andmolecular mecha-
nisms controlling the dormancy, or ‘‘hiber-
nation,’’ ofHSCs remainelusive. Ina recent
study in Cell, Nakauchi and colleagues
make the surprising finding that nonmyeli-
nating Schwann cells, a type of glia wrap-
ping around nerve fibers in the BM, consti-494 Cell Stem Cell 9, December 2, 2011 ª20tute a novel functional component of the
hematopoietic niche important for main-
taining HSC dormancy (Yamazaki et al.,
2011). Previously, the Nakauchi group re-
ported that TGF-b signaling induces HSC
quiescence by inhibiting raft microdomain
clustering and reducing activation of src
and signaling pathways that drive HSC
proliferation (Yamazaki et al., 2009). Inac-
tive TGF-b, in the form of a Large Latent
Complex (LLC), is known to be produced
by several cell types in the BM niche, in-
cludingHSCs.However,which constituent
of the hematopoietic niche would activate
TGF-b and make it available to HSCs re-
mained unclear (Yamazaki et al., 2009).
In their current paper, Nakauchi and
colleagues reveal that nonmyelinating11 Elsevier Inc.Schwann cells of the peripheral nervous
system are the major source of active
TGF-b in the BM. Schwann cells ensheath
peripheral neurons of the autonomic, i.e.,
the sympathetic and parasympathetic,
and the sensory nervous systems, by
tightly wrapping around axons. Myelinat-
ing Schwann cells insulate larger axons
but thin extensions such as the postgan-
glionic sympathetic axons in the BM are
ensheathed by nonmyelinating Schwann
cells. Activation of TGF-b depends on its
release from the LLC. In this complex,
TGF-b is kept inactive by Latency Associ-
ated Protein (LAP), which derives from the
TGF-b precursor and binds to Latent
TGF-b Binding Protein 1 (LTBP-1), which
tethers the complex to the extracellular
matrix. Yamazaki et al. found that integrin
b8, which is known to activate TGF-b from
the LLC, was specifically expressed by
nonmyelinating Schwann cells and colo-
calized with active TGF-b. Based on this,
the authors propose a model in which in-
tegrin avb8 binds to LAP to enable activa-
tion of TGF-b, potentially involving proteo-
lytic cleavage (Figure 1). The authors next
took advantage of the fact that glia
depend on trophic support from their
associated neurons and performed unilat-
eral transection of postganglionic sympa-
thetic nerves in the lumbar trunk to reduce
the number of active TGF-b producing
Schwann cells in the BM. While the total
number of BM cells was not affected by
this procedure, relative numbers of
HSCs in the BM were reduced and
HSCs displayed reduced levels of TGF-b
signaling as well as increased prolifera-
tion. This phenotype resembled that of
HSCs under reduced TGF-b signaling
conditions (Tgfbr2+/) and was reversed
by prior infusion of active TGF-b in the
denervated mice. BM denervation did
not affect the repopulating capacity of
the HSCs per se, nor did it trigger measur-
able egress of HSCs into the peripheral
blood or spleen. These observations
support the conclusion that active TGF-b
produced by Schwann cells controls HSC
dormancy in the BM but also raise some
interesting questions. Although denerva-
tion did not significantly change the
number of other niche cells, i.e., MSCs,
osteoblasts, or endothelial cells, it seems
possible that this procedure could have
resulted in functional changes in these or
other cell types of the hematopoietic
microenvironment. Furthermore, lack of
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Previewssympathetic innervation in itself, indepen-
dent from glia or TGF-b signaling, could
also have contributed to the observed
HSC defects.
In this context, it is noteworthy that
several recent reports have described
a functional role of the peripheral nervous
system (PNS) in the hematopoietic niche
(Katayama et al., 2006; Makhijani et al.,
2011; Me´ndez-Ferrer et al., 2008, 2010;
Spiegel et al., 2007). Studies by Frenette
and colleagues demonstrated regulation
of HSC trafficking and other behaviors by
the sympathetic nervous system, both
under physiological activation conditions
such as circadian inputs from the central
nervous system (Me´ndez-Ferrer et al.,
2008) and under experimental challenges
such as G-CSF stimulation (Katayama
et al., 2006). In both instances, sympa-
thetic adrenergic signals affect the
expression of CXCL12 in MSCs or osteo-
blasts, resulting in reduced signaling
through the corresponding receptor
CXCR4 on HSCs and HSC egress from
the BM (Katayama et al., 2006; Me´ndez-
Ferrer et al., 2008, 2010). Sympathetic
signals, such as the neurotransmitters
dopamine and norepinephrine, can also
trigger HSCs directly to regulate HSC
proliferation, migration, and mobilization;
their cognate receptors are expressed on
HSCs, in particular under G-CSF-induced
conditions (Spiegel et al., 2007).
Roles of the PNS in the hematopoietic
niche may be widely conserved across
phyla. Recently, genetics and live-
imaging studies in the Drosophila larvashowed that blood cells colonize hema-
topoietic ‘‘niches,’’ i.e., segmentally
repeated epidermal-muscular pockets
jointly shared with cells of the PNS, and
rely on the PNS for their localization and
trophic survival (Makhijani et al., 2011).
In vertebrates, the PNS is also a player
in the microenvironments of secondary
lymphoid organs and other, nonhemato-
poietic organ systems. Lymph nodes
and spleen are highly innervated by
sympathetic nerve fibers, which control
the maturation and regulation of T cells
and macrophages. This innervation
provides a direct anatomical link allowing
inputs from the central nervous system to
regulate physiological and pathological
immune responses (Straub, 2004). So
far, in all these systems, attention has
mostly been drawn to neuron-related
functions. The findings by Yamazaki
et al. challenge this existing view and
encourage parallel studies on the role of
glia relative to the contribution of neurons
in PNS-dependent niches.
An outstanding question arising from
the work by Nakauchi and colleagues is
whether the activity of Schwann cells
and the release of active TGF-b are regu-
lated by neural activity of the nerve fibers
they are ensheathing. In the PNS, sensory
neurons of the dorsal root ganglia directly
regulate their associated Schwann cells
by ATP-based purinergic signaling and
other neurotransmitters. This and similar
neuron-glia communications do not re-
quire synaptic contacts and can take
place at all neuron-glia interfaces, e.g.,Cell Stem Cell 9,along nerve fibers or at the somata of
neurons (Fields and Burnstock, 2006). By
which mechanisms nervous inputs may
control glial activity that affects the BM
and other hematopoietic or nonhemato-
poietic niches will be an intriguing topic
to explore in the future.REFERENCES
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